Pharmacy

The number of active drug shortages has declined sharply since June, according to the FDA’s drug shortage database. Seventy-five drugs were in shortage as of Dec. 30, down from 194 in mid-June. The decline reflects updates to the FDA’s database,…

From payer shifts to regulatory milestones, GLP-1 therapies for obesity and diabetes continued to reshape the healthcare landscape in December. Here are six updates: 

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date:  Note: The FDA’s information is current as of Dec. 18.  1. Phytonadione injection — For select coagulation disorders. 2.…

A federal judge granted a temporary restraining order blocking the Department of Health and Human Services from launching its 340B Rebate Model Pilot Program, which was scheduled to begin Jan. 1, 2026. U.S. District Judge Lance Walker of the District…

The FDA has accepted a biologics license application from Inovio for a potential treatment for adults with recurrent respiratory papillomatosis. Although the application was filed under the accelerated approval pathway, the FDA said in its acceptance letter that Inovio did…

As regulatory pressure mounts and workforce shortages persist, Louisville, Ky.-based Baptist Health System is positioning pharmacy as a safeguard for medication access and a driver of system growth. On an episode of the “Becker’s Pharmacy Leadership Podcast,” Nilesh Desai, chief…

The following hospitals and health systems have recently posted job listings for pharmacy leaders. Note: This is not an exhaustive list. Listings were compiled from job-seeker websites.

Here are eight recent drug shortages and discontinuations, according to the FDA’s drug supply databases:

CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. The announcement comes weeks following the White House’s agreements with Eli Lilly and Novo Nordisk to apply most-favored-nation…

As we look ahead to 2026, the operational demands on 340B programs are increasing across every dimension. Between the implementation of the 340B Rebate Model pilot and Maximum Fair Price (MFP) covered entities (CEs) are entering a period where manual…